Literature DB >> 7905358

Assessment of P-glycoprotein-dependent drug transport in isolated rat hepatocytes using rhodamine 123.

E Chieli1, E Santoni Rugiu, F Cervelli, A Paolicchi, R Tongiani.   

Abstract

To test the activity of P-170 glycoprotein in isolated hepatocytes, a method has been developed employing the fluorescent dye rhodamine 123 (R-123). The uptake of R-123 by both freshly isolated and 4-hr-plated hepatocytes depends on dye concentration, time of incubation, and cell number. The efflux of R-123 from cells is inhibited by sodium azide and by verapamil. In standard conditions the efficiency of efflux of R-123 from cells correlates with the relative amount of immunoblottable glycoprotein. The method has been applied to detection of P-170 activity in hepatocytes from animals of different ages as well as from carcinogen-treated animals. The proposed assay appears a simple and adequate tool for the functional assessment of multidrug transporter in liver.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7905358     DOI: 10.1007/bf00755602

Source DB:  PubMed          Journal:  Cell Biol Toxicol        ISSN: 0742-2091            Impact factor:   6.691


  10 in total

Review 1.  Multidrug resistance.

Authors:  I Pastan; M M Gottesman
Journal:  Annu Rev Med       Date:  1991       Impact factor: 13.739

2.  Reversal mechanism of multidrug resistance by verapamil: direct binding of verapamil to P-glycoprotein on specific sites and transport of verapamil outward across the plasma membrane of K562/ADM cells.

Authors:  K Yusa; T Tsuruo
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

3.  Use of fluorescent dyes as molecular probes for the study of multidrug resistance.

Authors:  A A Neyfakh
Journal:  Exp Cell Res       Date:  1988-01       Impact factor: 3.905

4.  The membrane transport system responsible for multidrug resistance is operating in nonresistant cells.

Authors:  A A Neyfakh; T V Dmitrevskaya; A S Serpinskaya
Journal:  Exp Cell Res       Date:  1988-10       Impact factor: 3.905

Review 5.  Aging and drug disposition: an update.

Authors:  D L Schmucker
Journal:  Pharmacol Rev       Date:  1985-06       Impact factor: 25.468

6.  Coinduction of MDR-1 multidrug-resistance and cytochrome P-450 genes in rat liver by xenobiotics.

Authors:  R K Burt; S S Thorgeirsson
Journal:  J Natl Cancer Inst       Date:  1988-11-02       Impact factor: 13.506

7.  Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage?

Authors:  R E Durand
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

8.  Overexpression of the multidrug resistance gene product in adult rat hepatocytes during primary culture.

Authors:  O Fardel; D Ratanasavanh; P Loyer; B Ketterer; A Guillouzo
Journal:  Eur J Biochem       Date:  1992-04-15

9.  Characterization of multidrug resistance by fluorescent dyes.

Authors:  D Kessel; W T Beck; D Kukuruga; V Schulz
Journal:  Cancer Res       Date:  1991-09-01       Impact factor: 12.701

10.  Expression of the multidrug-resistant gene in hepatocarcinogenesis and regenerating rat liver.

Authors:  S S Thorgeirsson; B E Huber; S Sorrell; A Fojo; I Pastan; M M Gottesman
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

  10 in total
  3 in total

1.  Influence of rat strain on P-glycoprotein expression in cultured hepatocytes.

Authors:  E Chieli; N Romiti; F Cervelli; A Paolicchi; R Tongiani
Journal:  Cell Biol Toxicol       Date:  1994-06       Impact factor: 6.691

2.  Decreased expression and activity of P-glycoprotein in rat liver during acute inflammation.

Authors:  M Piquette-Miller; A Pak; H Kim; R Anari; A Shahzamani
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

3.  In vitro Effects of Four Native Brazilian Medicinal Plants in CYP3A4 mRNA Gene Expression, Glutathione Levels, and P-Glycoprotein Activity.

Authors:  Andre L D A Mazzari; Flora Milton; Samantha Frangos; Ana C B Carvalho; Dâmaris Silveira; Francisco de Assis Rocha Neves; Jose M Prieto
Journal:  Front Pharmacol       Date:  2016-08-19       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.